CEA Industries believes the FDA’s authorization of JUUL sets an important precedent for product validation and regulatory clarity across the e-cigarette industry. The Company sees this development as paving the way for broader participation in the U.S. market under a more defined and predictable regulatory framework.

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story FDA reverses course on Juul The Food and Drug Administration is allowing Juul Labs to keep its electronic